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An in vitro model was developed to replicate hepatitis E virus (HEV) in normal primary cynomolgus macaque hepatocytes
using a hormonally defined, serum-free medium formulation. Primary hepatocytes were infected in tissue culture following
isolation by collagenase treatment of liver wedge biopsy material. Viral replication was monitored by a highly strand-specific
reverse transcription-polymerase chain reaction (RT-PCR) assay, which could detect the positive- and negative-strands of
HEV RNA independently in a sensitive and specific manner. Several infectious HEV (Burma strain) inocula were titered by
this RT-PCR assay, and a minimum effective infectious dose was determined. Appearance of newly replicated virus was
demonstrated by detection of both strands of HEV RNA in experimentally infected hepatocytes as well as the genomic
positive-strand viral RNA in the culture medium. Infectivity of the virus particles present in the media was confirmed by
serial passage and replication of the virus in culture. Using this in vitro infection system, a neutralization assay was developed
to assess the ability of anti-HEV antibodies to block virus infection of liver cells. Results presented in this report represent
the first in vitro demonstration of a neutralizing anti-HEV antibody directed against the ORF2-encoded putative capsid
protein. q 1997 Academic Press
INTRODUCTION newly synthesized, negative-strand viral RNA, a highly
strand-specific reverse transcription-polymerase chain
Hepatitis E virus (HEV) is one of several hepatotropic
reaction (RT-PCR) assay was developed to independently
viral agents causing inflammation of the liver. HEV is
detect and confirm the presence of positive- and nega-associated with an enterically transmitted form of acute
tive-strand RNA (Tam et al., 1996). Strand specificity overhepatitis, most prevalent in many developing countries.
a 10,000-fold concentration differential of synthetic RNALarge epidemics due to HEV infection in the endemic
templates was demonstrated and shown to be necessaryregions of southeast Asia, the former Soviet Union, Africa,
to avoid problems associated with false-priming duringand Mexico have been documented (Bradley, 1990; Brad-
cDNA synthesis and/or amplification of cDNA productsley et al., 1988). Early work on HEV indicated the extreme
by PCR. Using this assay, we previously reported thelabile nature of HEV under routine laboratory procedures
production and propagation of HEV in tissue culture fromsuch as freeze-thawing, pelleting, and exposure to salts,
in vivo-infected hepatocytes isolated from cynomolgusincluding CsCl (Bradley, 1990; Bradley et al., 1988). These
(cyno) monkeys (Tam et al., 1996). The isolated cynoobservations appeared to contradict the waterborne
hepatocytes were maintained in long-term culture usingmode of transmission of the virus and its ability to survive
a defined, serum-free medium (SFM) supplemented withunder harsh environmental conditions. Recently, HEV
growth factors and hormones capable of sustaining thehas been shown to exist in a number of animal hosts
highly differentiated liver cells in tissue culture (Jacob etincluding pigs, sheep, and rats (Balayan et al., 1990;
al., 1989, 1991; Lanford et al., 1989). The HEV-infectedClayson et al., 1995; Karentnyi et al., 1993; Maneerat et
cultures were shown to replicate and secrete virus-likeal., 1996; Ticehurst, 1991; Usmanov et al., 1994). This
particles into the medium for up to 65 days postisolationapparent HEV reservoir in the wild could be the source of
(Tam et al., 1996). This SFM-hepatocyte culture systemwater contamination observed in many of the epidemics
was also successfully used to propagate the hepatitis Caround the world.
virus (HCV) (Jacob et al., 1991; Lanford et al., 1994) asHEV is a single-stranded, positive-sense nonenve-
well as the hepatitis delta agent (Sureau et al., 1991,loped RNA virus and is presumed to replicate through a
1992, 1993).negative-strand intermediate in the synthesis of addi-
In this report, we demonstrate the in vitro infection oftional copies of the viral genome. In order to demonstrate
normal primary cyno hepatocytes with HEV. Presence of
newly replicated virus was illustrated by the detection of1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (415) 368-0907. both strands of viral RNA in infected cells and shedding
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of positive-strand genomic RNA into the culture medium. at 377 with periodic rocking. An additional 1 ml of SFM
was then added to the cultures and incubation was con-Infectivity of viral particles in the medium was confirmed
by serial passage experiments. An in vitro neutralization tinued overnight. After the removal of inocula, the cul-
tures were washed three times with Williams medium Eassay was also developed to demonstrate the neutraliz-
ing activity of anti-HEV antibodies against hepatitis E (WME) and refed with SFM. Culture medium was then
changed every 2–3 days until harvesting for PCR analy-infection. The availability of such an in vitro replication
model should enhance our ability to study the biologic sis. Unless indicated otherwise, all subsequent in vitro
HEV infections were carried out using an inoculum ofcharacteristics of HEV.
20-ml sample of a 1002 dilution of infectious bile on the
cyno primary hepatocytes.MATERIALS AND METHODS
Cyno monkeys and hepatocyte cultures Strand-specific RT-PCR assays
Liver wedge biopsies were performed on cynomolgus
The strand-specific RT-PCR assay used to determinemonkeys in accordance with a protocol approved by the
presence of positive- and negative-strand HEV RNA wasinstitutional animal care and use committee at Southwest
performed as previously described (Tam et al., 1996).Foundation for Biomedical Research. Hepatocytes were
Briefly, strand-specific primers were used to prime firstisolated from the liver tissues by the established two-
strand cDNA synthesis using the Mn2/-dependent re-step perfusion-collagenase treatment procedure (Jacob
verse transcriptase activity of the rTth polymerase. Theet al., 1989; Lanford et al., 1989). Isolated cells were
reverse transcriptase activity of rTth was then inactivatedplated and maintained in a hormonally defined serum-
by chelation of Mn2/ with EGTA. After addition of thefree medium (SFM) as previously described (Lanford et
appropriate opposite strand primer, the Mg2/-dependental., 1989). Hepatocytes were typically plated at 2 1 106
thermo-stable DNA polymerase activity of rTth was usedcells per well in rat-tail collagen-coated 6-well plates.
to amplify a targeted HEV genomic fragment in openingSFM was changed every 2–3 days until cultures were
reading frame one (ORF1) using the synthesized cDNAharvested on indicated days for experimental analysis.
as templates. Presence of PCR-amplified DNA from aFour separate hepatocyte isolations were carried out for
single round of 35 cycles of amplification was demon-the experiments reported here.
strated by the use of Southern hybridization with a 32P-
labeled internal probe. Starting RNA templates derivedIn vitro infection of primary hepatocytes and inocula
from a 50-ml culture medium sample or one-twelfth (1/12)
of the total cellular RNA isolated from individual wells ofSeveral inocula for in vitro infection were assessed by
a strand-specific RT-PCR (see below) assay to determine 6-well culture plates were used without exception for all
strand-specific RT-PCR. Duplicate cultures were invari-their HEV RNA titer. These inocula, collected from cynos
which had been experimentally infected with a 10% w/v ably utilized in all PCR analyses. While the strand specific-
ity and sensitivity of the PCR assays were periodicallystool sample from a third-passage cyno infected with
HEV-Burma strain (Tam et al., 1996), were as follows: validated using the full panel of synthetic RNA titration
over the 6 logs of concentration differences, individualbile at the time of scheduled surgical procedure for pro-
curement of liver tissue, sera at regular intervals around strand-specific RT-PCR experiments were routinely moni-
tored by the use of a 100-fold higher input RNA concentra-the time of elevated serum alanine aminotransferase
(ALT) levels indicative of induced clinical disease, and tion of the opposite orientation (Tam et al., 1996).
stool samples on a routine daily basis. RNA was ex-
tracted by the use of a RNAzol (Tel-Test, Inc., Friends- Infectivity of media-derived virus
wood, TX) procedure from 50-ml samples of bile and sera
directly as well as samples from a 10% (w:v) suspension To demonstrate the infectivity of the virus particles
produced in vitro, conditioned culture medium samplesof stool made in sterile phosphate-buffered saline (PBS).
Positive- and negative-strand HEV RNA titers were then were used in passage of virus experiments (see Fig. 4A).
Initially, an HEV RNA-positive medium sample collectedindependently determined from RNA extracted from neat
as well as serially diluted (1001 to 1005) samples by the from a hepatocyte culture derived from an in vivo-infected
cyno liver (27MEB) (20) was used to infect normal primaryRT-PCR assay to identify the inoculum with the highest
potential infectivity. hepatocytes (passage 1). One milliliter of media from
these passage 1 cultures was collected 10 days afterOnce bile was determined to be the preferred inocu-
lum, its infectivity on normal primary cyno hepatocytes infection and passed onto a second round of normal
primary hepatocyte cultures (passage 2). Media fromwas titrated across a five log concentration differential
by serial dilution. The inocula, routinely 20 ml of a 1001 these passage 2 cultures were then collected every 2-3
days and analyzed by RT-PCR. When determined to beto 1005 dilution of bile in sterile PBS with 10% fetal bovine
serum (FBS), were added to 1 ml SFM and used to inocu- HEV RNA-positive, selected medium samples were used
to further passage the virus onto primary hepatocyte cul-late individual wells of cultures in 6-well plates for 3 h
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tures. A total of 4 passages was carried out for the pur-
poses of these experiments.
In vitro neutralization of HEV inocula
To evaluate the ability of relevant anti-HEV antibodies
to block HEV infection in tissue culture, an in vitro neutral-
ization assay was developed. Total IgGs were purified
by the use of protein G Sepharose column chromatogra-
phy from polyclonal antisera obtained from animals im-
munized with different HEV ORF2 and ORF3 proteins or
antigens (see Results). The IgG preparations were then
concentrated using Centricon concentrators (Amicon,
Inc., Beverly, MA) to a protein concentration of 5–10 mg/
ml. Purified test IgGs were coincubated in a typical vol-
FIG. 1. Demonstration of detection specificity and sensitivity of HEV
ume of 100 ml with the virus inoculum at 377 for 1 h with strand-specific RT-PCR. Positive- and negative-strand synthetic HEV
gentle shaking prior to inoculating hepatocyte cultures RNA samples across a 6 log concentration differences from 1 fg to
100 pg in a background of 200 mg/ml of unrelated total cellular RNAwith the addition of 1 ml SFM. All subsequent culture
were subjected to the rTth strand-specific RT-PCR analysis. A depictsand harvest steps were handled in identical manners to
the hybridization results of amplified DNA products from the plus strandstandard in vitro infection protocol.
assay carried out on input RNA templates of both orientations. Results
Standardized microgram amounts of test IgGs (125 mg from the minus strand assay are shown in B. A 4- to 5-fold differential
per well of hepatocyte culture) were initially used in test- in detection differential was observed in both assays, and a detection
sensitivity of 1 fg (1,500 copies) of synthetic RNA could be consistentlying for potential neutralizing activity. However, ELISA
demonstrated. Neg represents PCR negative control amplification ofend-point titration (see below) results revealed signifi-
unrelated total cellular RNA.cant differences in the amount of anti-HEV positive IgGs
needed to give a detectable immunoassay signal. In or-
der to normalize the quantities of HEV-specific antibodies
strand assays were validated using highly purified syn-used in these in vitro neutralization assays, subsequent
thetic HEV transcripts. Positive and negative syntheticexperiments were conducted with equivalent amounts of
RNA strands of 1182 bp in length were produced by inserum antibody preparations based on their differential
vitro transcription, purified, and used in the rTth strand-ELISA end-point titers.
specific RT-PCR assay as described (Tam et al., 1996). As
shown in Fig. 1, input template-dependent hybridizationELISA end-point titration of serum IgGs
signals were obtained over a range of 6 logs of RNA
HEV ELISA assay for IgG antibodies was carried out concentrations, 1 fg (1,500 copies) to 100 pg (1.5 1 108
as described (Yarbough et al., 1994). Briefly, 200 ng of copies) for both the plus and minus strand assays. Mis-
the recombinant HEV ORF2-derived SG3 truncated capsid primed or falsely primed PCR products, presumably from
protein (Yarbough et al., 1994; Tam AW, unpublished data) the large number of opposite strand RNA molecules
was used to coat wells of polystyrene microtiter plates. present, were not detected until RNA templates of the
After washing and blocking, purified total IgG antibodies incorrect orientation reached 10 pg for the positive-
in fivefold serial dilutions starting with 10 mg were incu- strand assay, an amount 4 logs higher than the 1 fg
bated with the SG3 protein. Following addition of HRP- input of the correct strand. For the negative-strand assay,
conjugated second antibodies and substrate reaction, the significant hybridization signal was detected only with
plates were read at an absorbance of 490 nm. ELISA end- an input of 1.5 1 108 (100 pg) copies of positive-strand
point was determined by the lowest dilution of antibody synthetic RNA (Fig. 1B). As demonstrated, the HEV
that gave an O.D.490 reactivity reading above a cutoff value strand-specific RT-PCR assay gave at least a 10,000- to
corresponding to 30 standard deviations from the mean 100,000-fold concentration difference in detection speci-
of preinoculation sample O.D. readings. Ratios of the dif- ficity. In all subsequent RT-PCR experiments described
ferences in the ELISA end-points of relevant antibodies below, the authenticity and reliability of the strand-spe-
were utilized to normalize the amount of anti-HEV-specific cific amplification signals were monitored with the use
IgGs used in the in vitro neutralization assay. of 1 and 10 fg of appropriate strand synthetic RNA and
a 2-log higher input (100 fg) of opposite strand RNA.
RESULTS Even though the strand-specific PCR assays were not
designed to be quantitative, highly purified synthetic RNAStrand specificity and sensitivity of the RT-PCR assay
templates reproducibly yielded an input concentration-
dependent amplification signal. The use of tissue culture-To ensure the PCR amplification signals obtained in
the strand-specific RT-PCR assay were derived from RNA derived RNA templates, however, had generally pro-
duced more variable results from in vitro experimentstemplates of the correct orientation, the plus and minus
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tive- and negative-strand signals approaches the maxi-
mum differential of the strand-specific assay, it is not
certain that the negative-strand signals in these samples
represent negative-strand HEV RNA. As bile was deter-
mined to contain the highest viral RNA titer, and should
pose the least potential of contamination when used as
an inoculum, its infectivity titer was then further deter-
mined by titration experiments on normal primary hepato-
cytes.
Infectivity of bile on primary hepatocytes
As illustrated in Fig. 3, 20-ml aliquots of the bile inocu-
lum serially diluted over a 5 log concentration range (1001
to 1005) were used to infect primary cyno hepatocyte
cultures. Positive-strand HEV RNA was detected in total
cellular RNA harvested on day 14 postinfection with each
level of inocula. An inoculum-dependent PCR signal was
demonstrated over the experimental range of virus infec-
tion. Negative-strand viral RNA was also detected fromFIG. 2. PCR titer of virus-containing cyno bile inoculum. Strand-spe-
these infected cells, but the signal was no longer detect-cific RT-PCR assays were performed on RNA templates purified from
undiluted and serially diluted bile samples. Positive-strand PCR results able with a 1004 dilution of the inoculum. Although it
are presented in A, and negative-strand in B. Synthetic HEV RNA con- seemed unlikely, given the number of SFM changes over
trols used for the positive-strand assay were 1 and 10 fg positive-sense the course of the culture experiment, the possibility re-
and 100 fg negative-sense transcripts. Controls for the negative strand
mained that the positive-strand signals observed at 1004assay were corresponding amounts of synthetic RNA transcripts of
and 1005 dilutions could represent carry-over of the inoc-the opposite orientation, respectively. Neg indicates negative control
amplification of unrelated total cellular RNA. ulum. Since the negative-strand RNA could be consis-
tently detected from the infected cells with a 20-ml 1002
dilution of the bile inoculum, this was the standard dosewhere cultures were infected in a virus inoculum dosage-
used for all subsequent in vitro infections of primary he-dependent manner. For these samples, only an end-point
patocytes.determination of whether they were PCR-positive or
-negative was made.
Appearance of virus from HEV-infected hepatocytes
Titration of inocula The time course for the appearance of newly repli-
cated virus in the in vitro-infected hepatocytes was fol-To assess the titer of HEV in three different sources
of inocula used to infect hepatocyte cultures, strand-spe-
cific RT-PCR was performed on RNA extracted from
equivalent volumes of virus-containing bile, sera, and
stool specimens obtained from cynos experimentally in-
fected with proven HEV-Burma strain inocula. Bile and
sera were serially diluted in sterile PBS prior to RNA
extraction. Stool samples were collected at the time of
expected viremia, made into 10% w/v suspensions, seri-
ally diluted, and then RNA was similarly extracted. Re-
sults of the bile PCR titer determination are depicted in
Fig. 2. The virus-containing bile could be titrated out to
a dilution of 1005 with the positive-strand PCR assay.
Stool yielded a somewhat lower dilution signal at 1004,
while the titer of viral RNA present in the serum sample
was determined to be 100-fold lower (data not shown).
A negative-strand HEV RNA signal was also detected in
FIG. 3. Infectivity titration of the cyno bile inoculum. Positive (A)all three sources of inocula. This negative-strand signal
and negative (B) strand RT-PCR were performed on total cellular RNAwas found to be higher in the bile which could be de-
isolated from primary hepatocytes harvested 14 days postinoculationtected down to a 1002 dilution of the sample.
with the bile inocula. Duplicate cultures were used for each level of
Only undiluted RNA extracted from 50-ml samples of inoculum. RNA controls of 1 and 10 fg of appropriate-strand transcripts
stool suspension and sera yielded a faint negative-strand and 100 fg of the opposite-sense used were similar to those described
in the legend to Fig. 2.hybridization signal. Since the differential between posi-
AID VY 8817 / 6a51$$$201 10-14-97 09:33:35 viral AP: VY
98 TAM ET AL.
FIG. 4. Detection of positive- and negative-strand HEV RNA from in vitro-infected cultures of primary cyno hepatocytes. Total RNA was purified
from infected hepatocytes and cell-free culture media on indicated days postinfection. Strand-specific RT-PCR was then carried out with RNA
obtained from duplicate wells of cultures. PCR products from one round (35 cycles) of amplification were blotted and probed to detect HEV fragments
amplified from (A and C) positive-sense genomic strand and (B and D) negative replicative strand RNA templates. Lanes labeled ‘‘spike’’ depict PCR
products amplified from inoculum-spiked cell and medium fractions. The generation of these samples is described in the text. RNA control lanes
represent the appropriate synthetic RNA template controls for each assay as described. Lanes N indicate negative control amplification of unrelated
cellular RNA.
lowed over a 24-day period after inoculation. On the final the spiked samples was higher than that initially detected
in infected cultures (Figs. 4A and 4C, day 1), becauseday of culture, an inoculum identical to those used in the
original in vitro infection protocol was spiked into the infected cultures were washed extensively following in-
oculation. However, negative-strand signals were not ob-media as well as cells harvested from a set of duplicated
wells of uninfected hepatocyte cultures and then simi- served in these spiked samples, illustrating that any de-
tection of minus strand viral RNA could not have beenlarly processed by RT-PCR. These inoculum-spiked sam-
ples were designed to measure the maximum intensity due to a carry-over of the virus inoculum used to infect
the cells.of PCR signals that might be obtained from the cell cul-
tures, had the inocula been retained entirely either in the Intracellular positive- and negative-strand RNA were
detected from the infected cultures within 24 h after infec-culture medium or cell fraction without actually infecting
the primary hepatocytes. As shown in Fig. 4 depicting tion. Levels of positive-strand RNA were lower in infected
cells on day 1 compared to the spike but then increasedstrand-specific RT-PCR results from a typical time course
appearance of virus experiment, strong positive-strand over the next few days of culture to a significant level by
day 7 and were maintained throughout the duration ofHEV RNA signals were easily demonstrated in both the
spiked cell and medium fractions. The level of virus in the experiment. The negative, replicative RNA strand, un-
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detectable in the spike, was found to be just above detec- 4), the detection of its presence in the passage cells is
necessarily an indication of virus replication. Subsequenttion levels in the hepatocyte cellular RNA on day 1 but
continued to accumulate over the next 14 days of culture inoculation of cells (passage 4) with passage 3 culture
media led to the detection of cell-associated positive-(Fig. 4B). The high level of culture medium-derived posi-
tive genomic strand HEV RNA on day 1 post infection strand RNA; however, negative-strand RNA was not ob-
served, as their levels may have dropped below the levelwas most likely a reflection of the presence of carry-over
virus from the inocula. The RNA titer dropped significantly of sensitivity of the PCR assay. The passage 4 were held
in culture for 34 days before being infected; the extendedby day 3 (Fig. 4C), as expected due to dilution from
changes of SFM. Viral RNA then began to accumulate in time prior to experimental infection may have decreased
the susceptibility of these cells to HEV.the media, reaching an apparent peak level by day 14.
The morphology of the cultured hepatocytes did not ap-
pear to have undergone any discernible changes as a In vitro neutralization of HEV inocula
result of the apparent HEV infection. No cytolytic effects
With demonstration of the ability to consistently infectwere observed, indicating an on-going process of virus
cyno hepatocyte cultures in vitro, the infection protocolshedding by the infected cells. Negative-strand viral RNA
was modified to permit evaluation of anti-HEV antibodieswas not detected in the culture medium at any time after
that may potentially neutralize the virus and block infec-infection (Fig. 4D). Two separate time course experi-
tion. Total IgG antibodies were purified from animals ei-ments of appearance of virus from infected primary hepa-
ther hyperimmunized with specific HEV antigens or ex-tocytes were performed, each with independent confir-
perimentally infected with the virus. The capacity of thesemation of RT-PCR results using different aliquots of cell-
polyclonal antibodies to specifically bind and neutralizeand medium-derived RNA.
the virus was assessed by a coincubation step with the
inocula prior to exposure of the cultured hepatocytes.
Passage of infectious culture media
To determine whether viral RNA detected in the culture
medium was derived from infectious virus particles, me-
dia passage experiments were performed. Aliquots of
HEV PCR-positive media collected on day 8 postisolation
from in vivo-infected cyno hepatocytes placed in culture
(Tam et al., 1996) were used to infect normal primary
liver cell cultures (see Fig. 5A). Culture media from this
first passage, and each subsequent passage, were used
to inoculate succeeding primary cultures. The RT-PCR
results of passage 3 cellular RNA are presented in Figs.
5B and 5C. Inoculation with 200 and 1000 ml of the pas-
sage 2 media, which had been determined to be PCR-
positive for positive-strand RNA, resulted in the infection
of passage 3 cells. Strong positive- and low but detect-
able negative-strand signals were observed from pas-
sage 3B cellular RNA harvested 28 days after infection.
A 5-fold greater inoculum used to infect cultures resulted
in a correspondingly higher intracellular negative-strand
PCR signal (passage 3C), while a 10-fold lower inoculum
yielded undetectable signals (passage 3A). While the dif-
ferential signals observed between positive- and nega-
tive-strand RNA in passage 3B cells may approach the
limit of the strand specificity of the RT-PCR assay, as
mentioned in the virus inoculum PCR titration, the much
stronger negative-strand signal detected from passage
3C cells far-exceeded what could be expected of incor-
rect priming from positive-strand RNA templates, and
represented correctly amplified products from negative-
FIG. 5. Passage of infectious medium-derived virus. (A) A schematicstrand viral RNA. Positive-strand viral RNA was also de-
depicting the design of the serial passage of conditioned culture media.tected from culture media harvested throughout the en-
(B) Positive- and (C) negative-strand RT-PCR analysis of passage 3
tire duration of the passage 3 culture (data not shown). infected hepatocyte cellular RNA. Serum-free medium was added to
As negative-strand viral RNA has never been demon- the uninfected cultures in place of the inoculating conditioned media.
Lanes marked N were negative PCR controls.strated in the culture medium (Tam et al., 1996 and Fig.
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Convalescent phase cyno IgG antibodies apparently
failed to completely block virus adherence to the cells,
as evidenced by a detectable, albeit much decreased
(compared to preinfection serum Ig control) positive-
strand PCR signal. However, level of virus replication
was nevertheless altered in these cells. No detectable
negative-strand viral RNA was found. One plausible ex-
planation for this result is that the titer of specific anti-
HEV antibodies found in this preparation of cyno IgGs is
3–4 orders of magnitude lower than those from animals
hyperimmunized with defined HEV antigens, as con-
firmed by ELISA end-point titration of the various antibod-
ies. The amounts of purified rabbit IgGs still yielding a
detectable ELISA signal were in the pg range, while that
FIG. 6. In vitro neutralization of bile inocula with the rabbit anti-SG3
for the convalescent-phase cyno IgGs was found to beantibody. (A) Positive-strand RNA assay. (B) Negative-strand RNA assay.
100 ng. When the in vitro neutralization assay was re-Purified convalescent phase IgGs from (i) a rabbit immunized with the
ORF2-derived recombinant SG3 protein, (ii) a rabbit immunized with a peated using normalized amounts of IgGs based on
full-length ORF3 protein (described as anti-ORF3-8-5 in the text), and ELISA end-point titers relative to an amount of the anti-
(iii) a cyno experimentally infected with HEV were coincubated with the SG3 antibody previously determined to be neutralizing,
bile inocula for 1 h prior to exposure of the virus to the cultured cells.
anti-SG3 remained the only antibody capable of com-After removal of the inocula, culture was continued for 14 days until
pletely blocking viral infection.cellular RNA was isolated and analyzed for the presence or absence
of HEV RNA. Matched preimmunization serum IgGs were similarly puri-
fied and used as controls. Infected controls were obtained from cultures
DISCUSSIONinfected using the standard in vitro infection procedure. Negative PCR
and synthetic RNA controls were as previously described.
Research interest in HEV has risen since its molecular
identification and the progressive realization that its epi-
demiology is not limited to endemic areas in the devel-Two rabbit polyclonal antibodies, one (anti-ORF3-8-5) di-
rected against the complete protein encoded by opening oping world where general sanitation measures are an
everyday concern (Bradley, 1990; Bradley and Maynard,reading frame 3 (ORF3) (Tam et al., 1991) and one (anti-
SG3) directed against the SG3 protein encoded by the 1986; Bradley et al., 1988; Yarbough et al., 1994). The
need to understand the biology of HEV and its replicativecarboxyl terminal 327 amino acids of ORF2 (Tam et al.,
1991; Yarbough et al., 1994; Tam AW, unpublished data), strategy within the host is further illustrated by recent
papers describing the virus as potentially a zoonoticwere used along with a preparation of total serum IgGs
isolated from a convalescent phase cyno infected with agent (Balayan et al., 1990; Clayson et al., 1995, Karetnyi
et al., 1993; Maneerat et al., 1996; Ticehurst, 1991; Us-HEV. A qualitative end-point determination of absence
or presence of PCR signals was used to assess potential manov et al., 1994). In this report, we have extended our
ability to cultivate HEV from in vivo-infected hepatocytesantibody neutralizing activity in these in vitro neutraliza-
tion assays, as each IgG preparation appeared to differ- to the development of an in vitro infection system. We
also demonstrate the usefulness of this system forentially attenuate the infectivity of the virus inoculum, due
probably to nonspecific protein interaction. As shown in screening anti-HEV antibodies for potential neutralizing
activity.Fig. 6, the anti-SG3 antibody appeared to specifically
block the in vitro viral infection. The strong positive- Development of a strand-specific RT-PCR assay to de-
tect the positive genomic and newly synthesized nega-strand PCR signal observed in the infected culture con-
trols was completely diminished by coincubation of the tive replicative RNA strands for a positive-sense, single-
stranded RNA virus is imperative for the demonstrationanti-SG3 antibody with the virus inoculum. Negative-
strand viral RNA was not detected from these cultures, as of viral replication (Tam et al., 1996). The use of highly
purified synthetic HEV RNA to monitor the strand speci-expected when virus absorption by the antibody prevents
infection. IgGs purified from the matched preimmunized ficity and sensitivity of the PCR assays, together with
appropriate negative controls such as omission of RTserum failed to show similar effects in preventing the
in vitro infection. In contrast, the rabbit anti-ORF3-8-5 enzyme activity and/or oligo primers in the cDNA step,
allowed for unambiguous interpretation of the amplifica-polyclonal antibody did not exhibit detectable neutraliz-
ing activity, as infected cells displayed both positive- and tion results. The additional use of an inoculum-spiked
control, designed to address the issue of a potentialnegative-strand viral RNA on day 14 postinoculation. Two
other purified rabbit antibodies, directed against the carry-over of the inoculating virus stock, further ascer-
tained the origin of the detected viral RNA. Negative-known C-terminal 42 amino acid ORF2 3-2 epitope (Yar-
bough et al., 1991), were also found to be deficient in strand HEV RNA was not detected in any of the inoculum-
spiked cell-associated and medium-derived RNA sam-neutralizing the HEV inoculum (data not shown).
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ples, indicating that detection of negative-strand viral RNA detected in the infected cells, whereas only positive-
strand genomic RNA had been found in the conditionedRNA must have been a result of viral replication.
However, it is interesting to note that negative-strand medium used as inoculum. The window of potential in-
fectivity of cultured hepatocytes following collagenaseHEV RNA was detected in the various undiluted inocula
examined in this study. For HCV, the issue of extrahepatic isolation remains to be defined, as cells that were held
in culture for an extended period (34 days in passage 4)replication remains highly controversial. A recent report
demonstrated a lack of detection of negative strand HCV appeared less proficient in supporting viral replication.
Attempts to demonstrate the physical presence of theRNA in peripheral blood mononuclear cells and other
extrahepatic tissues using a similar strand-specific RT- virus by electron microscopy (EM) were, however, not
successful. Comparative densitometry scanning of thePCR method (Lanford et al., 1995). The association of
negative-strand viral RNA with lipid membrane structures medium-derived positive-strand RNA PCR signals with
the synthetic RNA controls (1 and 10 fg represent approx-may not necessarily indicate replication. What functional
role, if any, it may play in the biology of the virus remains imately 1,500 and 15,000 RNA copies, respectively)
yielded an estimated peak titer of about 105 viral ge-to be determined.
While bile and stool specimens from humans and ani- nomes per milliliter on day 14 postinfection, which is
below the level of direct EM or IEM detection. This levelmals known to be HEV-infected have been used success-
fully as inocula in animal models (Bradley, 1990; Bradley of replication still represents a significant amplification
of virus, as the cumulative aggregate of positive-strandet al., 1988; Reyes et al., 1990), their in vitro infectivity on
tissue culture cells had never been tested. The infectious viral RNA detected over the 24-day duration of the experi-
ment (i.e., summation of virus detected in infected cellstiter of standard fecal suspension (10%) containing HEV
has previously been shown to be approximately the same and all culture medium samples collected at SFM
changes) depicted in Fig. 4 exceeds the estimatedas its genome titer determined by RT-PCR (Tsarev et al.,
1994). Our results in the positive-strand PCR titer of the amount of virus in the inoculum with a PCR titer of about
105 per milliliter. Previously, we were unable to detectbile inoculum (Fig. 2) and its infectivity titration (Fig. 3)
on primary hepatocytes (both in the 1005 dilution range) the ORF2-encoded capsid protein by Western blot analy-
sis from cultured cyno hepatocytes that were in vivo-confirm this finding, suggesting that there may be very
low levels of defective or noninfectious particles in these infected (Tam et al., 1996).
Data presented here also delineated the presence ofsamples.
In this study, we sought to determine if primary hepato- a neutralizing anti-HEV antibody in the rabbit anti-SG3
antibody. This is the first demonstration of the preventioncytes, following isolation and placement into tissue cul-
ture, remain susceptible to virus infection and replication. of infection by HEV in vitro. The neutralizing effect of the
anti-SG3 antibody has since been consistently demon-Results from the bile inoculum titration experiment as
well as appearance of virus as measured by the strand- strated, as its use as a positive control for blocking virus
infection became incorporated in subsequent in vitrospecific RT-PCR assays clearly confirmed in vitro infec-
tion. Normal cyno hepatocytes, procured from different neutralization assays (Yarbough et al., 1997). The obser-
vation that an antibody directed against a larger regionliver wedge isolations, were reproducibly infected. Newly
synthesized negative-strand HEV RNA was unequivocally of the ORF2 protein, rather than the known smaller 3-2
epitope, proved capable of neutralizing HEV suggestsdetected from cellular RNA of the infected cells up to 28
days postinoculation. The amount of negative-strand the presence of additional important epitope(s) within the
carboxyl terminal of the putative capsid protein. Alterna-RNA was lower than that of the positive-strand RNA for
the first few days of culture, but began to accumulate tively, elicitation of a neutralizing response might require
the presence of a conformational epitope of which thereaching a sustained level by day 7. Evidence for a pro-
ductive infectious cycle was substantiated by the detec- smaller epitope could be a part. In either case, the advent
of a reliable tissue culture system for HEV replicationtion of genomic strands of HEV in the medium throughout
the length of the culture period. Similar to the previously and an in vitro neutralization assay should expedite map-
ping of the neutralizing epitope(s) and facilitate researchdescribed culture of in vivo-infected cyno hepatocytes
(Tam et al., 1996), these in vitro infected cells showed efforts in the development of a vaccine against HEV infec-
tion (Fuerst et al., 1996; Tsarev et al., 1996). While limitedno cytopathic effects from the viral infection. As the tissue
culture media were changed every 2–3 days, the detec- serial passage has been carried out thus far, further opti-
mization of the in vitro infection process should providetion of medium-derived viral RNA represented a persis-
tent shedding of virus by the infected cells. Furthermore, a framework efficient enough for the study of the basic
mechanism of HEV replication.the infectivity of the shed viruses was established by
three successful passage of HEV onto normal hepatocyte
cultures as depicted in Fig. 5. These passage results ACKNOWLEDGMENT
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